Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting

The International Dermatology Outcome Measures (IDEOM) initiative presented an update on their progress related to instruments for psoriasis (PsO) and psoriatic arthritis (PsA) patient-centered outcome measures at the 2021 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The lieatment Satisfaction working group presented the development of a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The group is beginning by assessing the validity and reliability of the instrument in PsO patient populations, with the ultimate goal of validating it for use in multiple dermatological diseases. The Musculoskeletal Symptoms working group discussed how implementation of a screening measurement tool in patients with PsO can help identify unknown diagnoses of PsA or prevent worsening of symptoms.

Automated summary

The IDEOM initiative provided an update on the development of patient-centered outcome measures for psoriasis and psoriatic arthritis at the GRAPPA annual meeting. The Treatment Satisfaction working group introduced a specific questionnaire for dermatological conditions, while the Musculoskeletal Symptoms working group discussed the implementation of a screening tool for identifying PsA in psoriasis patients or preventing symptom worsening.